John Hulburt

John Hulburt has a long and varied career in finance, beginning with their role as an Audit Senior at Arthur Andersen LLP in 1994. John then moved to Ernst & Young LLP as an Audit Manager in 1996. In 2001, they joined Bruker Daltonics as Chief Financial Officer, where they remained until 2004. John then became Chief Financial Officer at Datawatch Corp in 2004. In 2007, they took on the role of Corporate Controller at GreatPoint Energy, followed by a similar role at Atlantic Power Corporation in 2008. In 2015, they were appointed Sr. Director, Controller at Aegerion Pharmaceuticals, and then VP of Finance at Rhythm Pharmaceuticals Inc. in 2016. Most recently, they took on the role of VP of Finance at Rational Vaccines in 2021, and is currently VP of Finance at Vesalius Therapeutics.

John Hulburt attended Merrimack College from 1992 to 1994, where they earned a Bachelor of Science in Business Administration (BSBA) with a major in Accounting.